North America Drugs for Schistosomiasis Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Info Research
120 Pages
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.


Scope of the Report:
This report focuses on the Drugs for Schistosomiasis in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
Praziquantel
Oxamniquine
Other

Market Segment by Applications, can be divided into
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

There are 15 Chapters to deeply display the North America Drugs for Schistosomiasis market.

Chapter 1, to describe Drugs for Schistosomiasis Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Schistosomiasis, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Drugs for Schistosomiasis, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Drugs for Schistosomiasis market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Drugs for Schistosomiasis Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents
1 Market Overview
1.1 Drugs for Schistosomiasis Introduction
1.2 Market Analysis by Type
1.2.1 Praziquantel
1.2.2 Oxamniquine
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 S. haematobium
1.3.2 S. mansoni
1.3.3 S. japonicum
1.3.4 S. mekongi
1.3.5 S. intercalatum
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shin Poong
2.1.1 Profile
2.1.2 Drugs for Schistosomiasis Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Shin Poong News
2.2 Merck
2.2.1 Profile
2.2.2 Drugs for Schistosomiasis Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Merck News
2.3 Bayer
2.3.1 Profile
2.3.2 Drugs for Schistosomiasis Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Bayer News
2.4 EIPICO
2.4.1 Profile
2.4.2 Drugs for Schistosomiasis Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 EIPICO News
2.5 Chandra Bhagat Pharma
2.5.1 Profile
2.5.2 Drugs for Schistosomiasis Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Chandra Bhagat Pharma News
2.6 Taj Pharmaceuticals
2.6.1 Profile
2.6.2 Drugs for Schistosomiasis Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Taj Pharmaceuticals News
3 North America Drugs for Schistosomiasis Market Competition, by Manufacturer
3.1 North America Drugs for Schistosomiasis Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Drugs for Schistosomiasis Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Drugs for Schistosomiasis Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share
3.4.2 Top 5 Drugs for Schistosomiasis Manufacturer Market Share
3.5 Market Competition Trend
4 North America Drugs for Schistosomiasis Market Analysis by Countries
4.1 North America Drugs for Schistosomiasis Sales Market Share by Countries
4.2 North America Drugs for Schistosomiasis Sales by Countries (2012-2017)
4.3 North America Drugs for Schistosomiasis Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Drugs for Schistosomiasis by Type
5.1 North America Drugs for Schistosomiasis Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Drugs for Schistosomiasis Sales and Market Share by Type (2012-2017)
5.1.2 North America Drugs for Schistosomiasis Revenue and Market Share by Type (2012-2017)
5.2 Praziquantel Sales Growth and Price
5.2.1 North America Praziquantel Sales Growth (2012-2017)
5.2.2 North America Praziquantel Price (2012-2017)
5.3 Oxamniquine Sales Growth and Price
5.3.1 North America Oxamniquine Sales Growth (2012-2017)
5.3.2 North America Oxamniquine Price (2012-2017)
5.4 Other Sales Growth and Price
5.4.1 North America Other Sales Growth (2012-2017)
5.4.2 North America Other Price (2012-2017)
6 North America Market Segmentation Drugs for Schistosomiasis by Application
6.1 North America Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
6.2 S. haematobium Sales Growth (2012-2017)
6.3 S. mansoni Sales Growth (2012-2017)
6.4 S. japonicum Sales Growth (2012-2017)
6.5 S. mekongi Sales Growth (2012-2017)
6.6 S. intercalatum Sales Growth (2012-2017)
7 United States Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Drugs for Schistosomiasis Sales and Market Share by Type
7.3 United States Drugs for Schistosomiasis Sales by Application (2012-2017)
7.4 United States Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Drugs for Schistosomiasis Sales and Market Share by Manufacturer
7.4.2 United States Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
7.5 United States Drugs for Schistosomiasis Export and Import (2012-2017)
8 Canada Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Drugs for Schistosomiasis Sales and Market Share by Type
8.3 Canada Drugs for Schistosomiasis Sales by Application (2012-2017)
8.4 Canada Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Drugs for Schistosomiasis Sales and Market Share by Manufacturer
8.4.2 Canada Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
8.5 Canada Drugs for Schistosomiasis Export and Import (2012-2017)
9 Mexico Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Drugs for Schistosomiasis Sales and Market Share by Type
9.3 Mexico Drugs for Schistosomiasis Sales by Application (2012-2017)
9.4 Mexico Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Drugs for Schistosomiasis Sales and Market Share by Manufacturer
9.4.2 Mexico Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
9.5 Mexico Drugs for Schistosomiasis Export and Import (2012-2017)
10 Drugs for Schistosomiasis Market Forecast (2017-2022)
10.1 North America Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
10.2 Drugs for Schistosomiasis Market Forecast by Countries (2017-2022)
10.2.1 United States Drugs for Schistosomiasis Forecast (2017-2022)
10.2.2 Canada Drugs for Schistosomiasis Forecast (2017-2022)
10.2.3 Mexico Drugs for Schistosomiasis Forecast (2017-2022)
10.3 Drugs for Schistosomiasis Market Forecast by Type (2017-2022)
10.4 Drugs for Schistosomiasis Market Forecast by Application (2017-2022)
11 Drugs for Schistosomiasis Manufacturing Cost Analysis
11.1 Drugs for Schistosomiasis Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drugs for Schistosomiasis
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Drugs for Schistosomiasis Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source


List of Tables and Figures

Figure Drugs for Schistosomiasis Picture
Table Product Specifications of Drugs for Schistosomiasis
Figure North America Sales Market Share of Drugs for Schistosomiasis by Types in 2016
Table Types of Drugs for Schistosomiasis
Figure Praziquantel Picture
Table Major Manufacturers of Praziquantel
Figure Oxamniquine Picture
Table Major Manufacturers of Oxamniquine
Figure Other Picture
Table Major Manufacturers of Other
Table North America Drugs for Schistosomiasis Sales Market Share by Applications in 2016
Table Applications of Drugs for Schistosomiasis
Figure S. haematobium Picture
Figure S. mansoni Picture
Figure S. japonicum Picture
Figure S. mekongi Picture
Figure S. intercalatum Picture
Figure United States Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Table Shin Poong Basic Information, Manufacturing Base and Competitors
Table Shin Poong Drugs for Schistosomiasis Type and Applications
Table Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Drugs for Schistosomiasis Type and Applications
Table Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Schistosomiasis Type and Applications
Table Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EIPICO Basic Information, Manufacturing Base and Competitors
Table EIPICO Drugs for Schistosomiasis Type and Applications
Table EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Type and Applications
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Drugs for Schistosomiasis Type and Applications
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure North America Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure North America Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table North America Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure North America Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure North America Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table North America Drugs for Schistosomiasis Price by Manufacturers (2016-2017)
Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2016
Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2017
Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2016
Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2017
Figure North America Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table North America Drugs for Schistosomiasis Sales by Countries (2012-2017)
Table North America Drugs for Schistosomiasis Sales Market Share by Countries (2012-2017)
Figure North America 2012 Drugs for Schistosomiasis Sales Market Share by Countries
Figure North America 2016 Drugs for Schistosomiasis Sales Market Share by Countries
Figure North America Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Table North America Drugs for Schistosomiasis Revenue by Countries (2012-2017)
Table North America Drugs for Schistosomiasis Revenue Market Share by Countries (2012-2017)
Table North America 2012 Drugs for Schistosomiasis Revenue Market Share by Countries
Table North America 2016 Drugs for Schistosomiasis Revenue Market Share by Countries
Table North America Drugs for Schistosomiasis Sales by Type (2012-2017)
Table North America Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Table North America Drugs for Schistosomiasis Revenue by Type (2012-2017)
Table North America Drugs for Schistosomiasis Revenue Share by Type (2012-2017)
Figure North America Praziquantel Sales Growth (2012-2017)
Figure North America Praziquantel Price (2012-2017)
Figure North America Oxamniquine Sales Growth (2012-2017)
Figure North America Oxamniquine Price (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure North America Other Price (2012-2017)
Table North America Drugs for Schistosomiasis Sales by Application (2012-2017)
Table North America Drugs for Schistosomiasis Sales Share by Application (2012-2017)
Figure North America S. haematobium Sales Growth (2012-2017)
Figure North America S. mansoni Sales Growth (2012-2017)
Figure North America S. japonicum Sales Growth (2012-2017)
Figure North America S. mekongi Sales Growth (2012-2017)
Figure North America S. intercalatum Sales Growth (2012-2017)
Figure United States Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure United States Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table United States Drugs for Schistosomiasis Sales by Type (2012-2017)
Table United States Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table United States Drugs for Schistosomiasis Sales by Application (2012-2017)
Table United States Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table United States Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure United States Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure United States Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table United States Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure United States Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure United States Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table United States Drugs for Schistosomiasis Export and Import (2012-2017)
Figure Canada Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Canada Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Canada Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Canada Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Canada Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Canada Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table Canada Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Canada Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Canada Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Canada Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Canada Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure Canada Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table Canada Drugs for Schistosomiasis Export and Import (2012-2017)
Figure Mexico Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Mexico Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Mexico Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Mexico Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Mexico Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Mexico Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table Mexico Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Mexico Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Mexico Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Mexico Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Mexico Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure Mexico Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table Mexico Drugs for Schistosomiasis Export and Import (2012-2017)
Figure North America Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
Table North America Drugs for Schistosomiasis Sales Forecast by Countries (2017-2022)
Table North America Drugs for Schistosomiasis Market Share Forecast by Countries (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Forecast (2017-2022)
Figure Canada Drugs for Schistosomiasis Sales Forecast (2017-2022)
Figure Mexico Drugs for Schistosomiasis Sales Forecast (2017-2022)
Table North America Drugs for Schistosomiasis Sales Forecast by Type (2017-2022)
Table North America Drugs for Schistosomiasis Market Share Forecast by Type (2017-2022)
Table North America Drugs for Schistosomiasis Sales Forecast by Application (2017-2022)
Table North America Drugs for Schistosomiasis Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure Drugs for Schistosomiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
Table Major Buyers of Drugs for Schistosomiasis
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

Asia-Pacific Vaginal Pessary Market by Manufacturers, Regions, Type and Application, Forecast to 2022

GIR 2017-11-23 Pharma & Healthcare

"This report studies the Vaginal Pessary market, a vaginal pessary is a removable device placed into...Read More

Asia-Pacific Healthcare Workforce Management System Market by Manufacturers, Regions, Type and Application, Forecast to 2022

GIR 2017-11-23 Pharma & Healthcare

Workforce management is an institutional process that maximizes performance levels and competency fo...Read More

Report's License Type

$4480
$8960

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.